Sodium phosphate p-32 - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sodium phosphate p-32 and what is the scope of freedom to operate?
Sodium phosphate p-32
is the generic ingredient in two branded drugs marketed by Bracco and Mallinckrodt, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for sodium phosphate p-32
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Clinical Trials: | 177 |
| Patent Applications: | 4 |
| DailyMed Link: | sodium phosphate p-32 at DailyMed |
Recent Clinical Trials for sodium phosphate p-32
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Quince Therapeutics S.p.A. | Phase 3 |
| Biotrial | Phase 3 |
| Insel Gruppe AG, University Hospital Bern | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for sodium phosphate p-32
US Patents and Regulatory Information for sodium phosphate p-32
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | SODIUM PHOSPHATE P 32 | sodium phosphate p-32 | SOLUTION;INJECTION, ORAL | 011777-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mallinckrodt | SODIUM PHOSPHATE P 32 | sodium phosphate p-32 | SOLUTION;INJECTION, ORAL | 011777-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bracco | PHOSPHOTOPE | sodium phosphate p-32 | SOLUTION;INJECTION, ORAL | 010927-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
